loadpatents
Patent applications and USPTO patent grants for Gillies; Stephen D..The latest application filed is for "influenza vaccines and methods of use thereof".
Patent | Date |
---|---|
Influenza Vaccines And Methods Of Use Thereof App 20220073648 - Gillies; Stephen D. | 2022-03-10 |
Anti-cancer antibodies with reduced complement fixation Grant 10,633,452 - Gillies | 2020-04-28 |
Antibodies and immunocytokines Grant 10,604,576 - Campbell , et al. | 2020-03-31 |
Anti-cancer Antibodies With Reduced Complement Fixation App 20190031769 - Gillies; Stephen D. | 2019-01-31 |
Anti-ICOS antibodies Grant 9,957,323 - Sainson , et al. May 1, 2 | 2018-05-01 |
Anti-icos Antibodies App 20180066058 - SAINSON; Richard Charles Alfred ;   et al. | 2018-03-08 |
Antibodies And Immunocytokines App 20170362321 - Campbell; Jamie ;   et al. | 2017-12-21 |
Anti-Cancer Antibodies With Reduced Complement Fixation App 20170210817 - Gillies; Stephen D. | 2017-07-27 |
Influenza Vaccines And Methods Of Use Thereof App 20170198061 - Gillies; Stephen D. | 2017-07-13 |
Antibodies and immunocytokines Grant 9,617,338 - Campbell , et al. April 11, 2 | 2017-04-11 |
Anti-cancer antibodies with reduced complement fixation Grant 9,617,349 - Gillies April 11, 2 | 2017-04-11 |
Antibodies and immunocytokines Grant 9,567,399 - Campbell , et al. February 14, 2 | 2017-02-14 |
Combination therapy using anti-EGFR and anti-HER2 antibodies Grant 9,522,956 - Gillies , et al. December 20, 2 | 2016-12-20 |
Reducing The Immunogenicity Of Fusion Proteins App 20150141626 - Gillies; Stephen D. ;   et al. | 2015-05-21 |
Combination Therapy Using Anti-EGFR And Anti-HER2 Antibodies App 20150132308 - Gillies; Stephen D. ;   et al. | 2015-05-14 |
Anti-Cancer Antibodies With Reduced Complement Fixation App 20150065691 - Gillies; Stephen D. | 2015-03-05 |
Reducing the immunogenicity of fusion proteins Grant 8,926,973 - Gillies , et al. January 6, 2 | 2015-01-06 |
Light Chain Immunoglobulin Fusion Proteins And Methods Of Use Thereof App 20140294758 - Gillies; Stephen D. | 2014-10-02 |
Anti-cancer antibodies with reduced complement fixation Grant 8,835,606 - Gillies September 16, 2 | 2014-09-16 |
Expression and export of angiogenesis inhibitors as immunofusins Grant 8,703,908 - Lo , et al. April 22, 2 | 2014-04-22 |
FC-Interferon-Beta Fusion Proteins App 20140005361 - Gillies; Stephen D. ;   et al. | 2014-01-02 |
Stabilization of Fc-interferon-beta fusion proteins Grant 8,557,232 - Gillies , et al. October 15, 2 | 2013-10-15 |
Expression And Export Of Angiogenesis Inhibitors As Immunofusins App 20130165634 - Lo; Kin-Ming ;   et al. | 2013-06-27 |
Immunocytokine sequences and uses thereof Grant 8,470,991 - Gillies , et al. June 25, 2 | 2013-06-25 |
Methods For Enhancing The Efficacy Of Il-2 Mediated Immune Responses App 20130017168 - Gillies; Stephen D. ;   et al. | 2013-01-17 |
IL-7 fusion proteins Grant 8,338,575 - Lauder , et al. December 25, 2 | 2012-12-25 |
CD20-binding polypeptide compositions for treating autoimmune disease Grant 8,337,844 - Carr , et al. December 25, 2 | 2012-12-25 |
Reducing The Immunogenicity Of Fusion Proteins App 20120309936 - Gillies; Stephen D. ;   et al. | 2012-12-06 |
CD20-Binding Polypeptide Compositions and Methods App 20120183545 - Carr; Francis Joseph ;   et al. | 2012-07-19 |
Expression and export of angiogenesis inhibitors as immunofusins Grant 8,206,718 - Lo , et al. June 26, 2 | 2012-06-26 |
CD20-binding polypeptide compositions and methods Grant 8,147,832 - Carr , et al. April 3, 2 | 2012-04-03 |
Proteins comprising an IgG2 domain Grant 8,066,994 - Gillies , et al. November 29, 2 | 2011-11-29 |
Methods of using Fc-cytokine fusion proteins Grant 8,043,608 - Gillies , et al. October 25, 2 | 2011-10-25 |
Il-7 Fusion Proteins App 20110243887 - Lauder; Scott ;   et al. | 2011-10-06 |
Reducing the immunogenicity of fusion proteins Grant 7,973,150 - Gillies , et al. July 5, 2 | 2011-07-05 |
IL-7 fusion proteins Grant 7,960,514 - Lauder , et al. June 14, 2 | 2011-06-14 |
Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens Grant 7,955,590 - Gillies , et al. June 7, 2 | 2011-06-07 |
Interleukin-6 Antagonists App 20110038877 - Way; Jeffrey ;   et al. | 2011-02-17 |
DNA encoding IL-2 fusion proteins with modulated selectivity Grant 7,888,071 - Gillies , et al. February 15, 2 | 2011-02-15 |
Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation Grant 7,879,319 - Gillies , et al. February 1, 2 | 2011-02-01 |
Enhancement Of Antibody-cytokine Fusion Protein Mediated Immune Responses By Combined Treatment With Immunocytokine Uptake Enhancing Agents App 20100297060 - GILLIES; STEPHEN D. ;   et al. | 2010-11-25 |
Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies Grant 7,833,976 - Lode , et al. November 16, 2 | 2010-11-16 |
Recombinant tumor specific antibody and use thereof Grant 7,803,618 - Gillies , et al. September 28, 2 | 2010-09-28 |
Enhancing the circulating half-life of antibody-based fusion proteins Grant 7,790,415 - Gillies , et al. September 7, 2 | 2010-09-07 |
Immunocytokine Sequences and Uses Thereof App 20100210831 - GILLIES; STEPHEN D. ;   et al. | 2010-08-19 |
Immunocytokine sequences and uses thereof Grant 7,767,405 - Gillies , et al. August 3, 2 | 2010-08-03 |
Recombinant Tumor Specific Antibody And Use Thereof App 20100174056 - Gillies; Stephen D. ;   et al. | 2010-07-08 |
Methods of using Fc-Cytokine fusion proteins App 20100068175 - Gillies; Stephen D. ;   et al. | 2010-03-18 |
Fc-interferon-beta fusion proteins Grant 7,670,595 - Gillies , et al. March 2, 2 | 2010-03-02 |
Reducing The Immunogenicity Of Fusion Proteins App 20100016562 - Gillies; Stephen D. ;   et al. | 2010-01-21 |
Heterodimeric Fusion Proteins Useful For Targeted Immune Therapy And General Immune Stimulation App 20100015089 - Gillies; Stephen D. ;   et al. | 2010-01-21 |
Enhancing The Circulating Half-life Of Antibody-based Fusion Proteins App 20090264627 - Gillies; Stephen D. ;   et al. | 2009-10-22 |
Reducing the immunogenicity of fusion proteins Grant 7,601,814 - Gillies , et al. October 13, 2 | 2009-10-13 |
IL-7 variants with reduced immunogenicity Grant 7,589,179 - Gillies , et al. September 15, 2 | 2009-09-15 |
Methods of targeting multiple cytokines Grant 7,582,288 - Gillies , et al. September 1, 2 | 2009-09-01 |
Combination Therapy Using Anti-EGFR and Anti-HER2 Antibodies App 20090214541 - Gillies; Stephen D. ;   et al. | 2009-08-27 |
Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation Grant 7,576,193 - Gillies , et al. August 18, 2 | 2009-08-18 |
Assembly And Folding Of Fc-interferon-beta Fusion Proteins App 20090191154 - Gillies; Stephen D. ;   et al. | 2009-07-30 |
Anti-Cancer Antibodies With Reduced Complement Fixation App 20090148441 - Gillies; Stephen D. | 2009-06-11 |
Il-2 Fusion Proteins With Modulated Selectivity App 20090098609 - Gillies; Stephen D. ;   et al. | 2009-04-16 |
Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents Grant 7,517,526 - Gillies , et al. April 14, 2 | 2009-04-14 |
Fc-erythropoietin Fusion Protein With Improved Pharmacokinetics App 20090092607 - Gillies; Stephen D. ;   et al. | 2009-04-09 |
Enhancing the circulating half-life of antibody-based fusion proteins Grant 7,507,406 - Gillies , et al. March 24, 2 | 2009-03-24 |
Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies App 20090060864 - Lode; Holger N. ;   et al. | 2009-03-05 |
IL-7 Fusion Proteins App 20090010875 - Lauder; Scott ;   et al. | 2009-01-08 |
Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation App 20080311655 - Gillies; Stephen D. ;   et al. | 2008-12-18 |
Fc-erythropoietin fusion protein with improved pharmacokinetics Grant 7,465,447 - Gillies , et al. December 16, 2 | 2008-12-16 |
Cancer treatments including administering IL-2 fusion proteins with modulated selectivity Grant 7,462,350 - Gillies , et al. December 9, 2 | 2008-12-09 |
Recombinant tumor specific antibody and use thereof Grant 7,459,538 - Gillies , et al. December 2, 2 | 2008-12-02 |
Anti-cancer antibodies with reduced complement fixation Grant 7,432,357 - Gillies October 7, 2 | 2008-10-07 |
Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies Grant 7,365,054 - Lode , et al. April 29, 2 | 2008-04-29 |
Methods for enhancing the efficacy of IL-2 mediated immune responses App 20080025947 - Gillies; Stephen D. ;   et al. | 2008-01-31 |
IL-7 fusion proteins Grant 7,323,549 - Lauder , et al. January 29, 2 | 2008-01-29 |
Multiple cytokine protein complexes App 20070258944 - Gillies; Stephen D. ;   et al. | 2007-11-08 |
Interleukin-6 antagonists App 20070178098 - Way; Jeffrey ;   et al. | 2007-08-02 |
Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation Grant 7,226,998 - Gillies , et al. June 5, 2 | 2007-06-05 |
Compositions and methods for treating tumors presenting survivin antigens App 20070104689 - Gillies; Stephen D. ;   et al. | 2007-05-10 |
Immunocytokine sequences and uses thereof App 20070059282 - Gillies; Stephen D. ;   et al. | 2007-03-15 |
IL-2 fusion proteins with modulated selectivity Grant 7,186,804 - Gillies , et al. March 6, 2 | 2007-03-06 |
IL-2 fusion proteins with modulated selectivity App 20070036752 - Gillies; Stephen D. ;   et al. | 2007-02-15 |
Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies App 20070036751 - Lode; Holger N. ;   et al. | 2007-02-15 |
Immunocytokine sequences and uses thereof Grant 7,169,904 - Gillies , et al. January 30, 2 | 2007-01-30 |
Expression and export of angiogenesis inhibitors as immunofusins App 20070009538 - Lo; Kin-Ming ;   et al. | 2007-01-11 |
Expression technology for proteins containing a hybrid isotype antibody moiety Grant 7,148,321 - Gillies , et al. December 12, 2 | 2006-12-12 |
Multiple cytokine protein complexes Grant 7,141,651 - Gillies , et al. November 28, 2 | 2006-11-28 |
Expression technology for proteins containing a hybrid isotype antibody moiety App 20060263856 - Gillies; Stephen D. ;   et al. | 2006-11-23 |
Assembly and folding of Fc-interferon-beta fusion proteins App 20060228332 - Gillies; Stephen D. ;   et al. | 2006-10-12 |
Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies Grant 7,115,261 - Lode , et al. October 3, 2 | 2006-10-03 |
Enhancing the circulating half-life of antibody-based fusion proteins App 20060194952 - Gillies; Stephen D. ;   et al. | 2006-08-31 |
Enhancing the circulating half-life of antibody-based fusion proteins Grant 7,091,321 - Gillies , et al. August 15, 2 | 2006-08-15 |
IL-7 variants with reduced immunogenicity App 20060141581 - Gillies; Stephen D. ;   et al. | 2006-06-29 |
Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens Grant 7,067,110 - Gillies , et al. June 27, 2 | 2006-06-27 |
Enhancing the circulating half-life of antibody-based fusion proteins App 20060034836 - Gillies; Stephen D. ;   et al. | 2006-02-16 |
Reducing the immunogenicity of fusion proteins App 20060025573 - Gillies; Stephen D. ;   et al. | 2006-02-02 |
Reducing the immunogenicity of fusion proteins Grant 6,992,174 - Gillies , et al. January 31, 2 | 2006-01-31 |
Recombinant tumor specific antibody and use thereof Grant 6,969,517 - Gillies , et al. November 29, 2 | 2005-11-29 |
Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens App 20050261229 - Gillies, Stephen D. ;   et al. | 2005-11-24 |
Recombinant tumor specific antibody and use thereof App 20050244418 - Gillies, Stephen D. ;   et al. | 2005-11-03 |
Fc-erythropoietin fusion protein with improved pharmacokinetics App 20050202538 - Gillies, Stephen D. ;   et al. | 2005-09-15 |
Anti-cancer antibodies with reduced complement fixation App 20050202021 - Gillies, Stephen D. | 2005-09-15 |
Fc-erythropoietin fusion protein with improved pharmacokinetics App 20050192211 - Gillies, Stephen D. ;   et al. | 2005-09-01 |
IL-7 fusion proteins App 20050164352 - Lauder, Scott ;   et al. | 2005-07-28 |
Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation App 20050137384 - Gillies, Stephen D. ;   et al. | 2005-06-23 |
Enhancing the circulating half-life of interleukin-2 proteins App 20050069521 - Gillies, Stephen D. ;   et al. | 2005-03-31 |
CD20-Binding polypeptide compositions and methods App 20050069545 - Carr, Francis Joseph ;   et al. | 2005-03-31 |
Expression and export of interferon-alpha proteins as Fc fusion proteins App 20050042729 - Lo, Kin-Ming ;   et al. | 2005-02-24 |
Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation Grant 6,838,260 - Gillies , et al. January 4, 2 | 2005-01-04 |
Immunocytokine sequences and uses thereof App 20040203100 - Gillies, Stephen D. ;   et al. | 2004-10-14 |
IL-15 immunoconjugates and uses thereof App 20040180035 - Gillies, Stephen D. | 2004-09-16 |
Multiple cytokine protein complexes App 20040072299 - Gillies, Stephen D. ;   et al. | 2004-04-15 |
Expression and export of anti-obesity proteins as Fc fusion proteins App 20040053366 - Lo, Kin-Ming ;   et al. | 2004-03-18 |
Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with prostaglandin inhibitor App 20040033210 - Gillies, Stephen D. | 2004-02-19 |
Multiple cytokine protein complexes Grant 6,617,135 - Gillies , et al. September 9, 2 | 2003-09-09 |
Immunocytokines with modulated selectivity App 20030166163 - Gillies, Stephen D. | 2003-09-04 |
Reducing the immunogenicity of fusion proteins App 20030166877 - Gillies, Stephen D. ;   et al. | 2003-09-04 |
Recombinant tumor specific antibody and use thereof App 20030157054 - Gillies, Stephen D. ;   et al. | 2003-08-21 |
Expression and export of angiogenesis inhibitors as immunofusins App 20030139365 - Lo, Kin-Ming ;   et al. | 2003-07-24 |
Cytokine immunoconjugates App 20030139575 - Gillies, Stephen D. | 2003-07-24 |
Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents App 20030049227 - Gillies, Stephen D. ;   et al. | 2003-03-13 |
Expression technology for proteins containing a hybrid isotype antibody moiety App 20030044423 - Gillies, Stephen D. ;   et al. | 2003-03-06 |
Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation App 20020193570 - Gillies, Stephen D. ;   et al. | 2002-12-19 |
Enhancing the circulating half-life of antibody-based fusion proteins App 20020147311 - Gillies, Stephen D. ;   et al. | 2002-10-10 |
Cytokine immunoconjugates App 20020146388 - Gillies, Stephen D. | 2002-10-10 |
Expression and export of interferon-alpha proteins as Fc fusion proteins App 20020081664 - Lo, Kin-Ming ;   et al. | 2002-06-27 |
E.coli Produced Immunoglobulin Constructs App 20020037558 - LO, KIN-MING ;   et al. | 2002-03-28 |
Expression induction method Grant 5,741,682 - Lo , et al. April 21, 1 | 1998-04-21 |
Expression and export technology of proteins as immunofusins Grant 5,726,044 - Lo , et al. March 10, 1 | 1998-03-10 |
Recombinant antibody cytokine fusion proteins Grant 5,650,150 - Gillies July 22, 1 | 1997-07-22 |
Expression and export technology of proteins as immunofusins Grant 5,541,087 - Lo , et al. July 30, 1 | 1996-07-30 |
Method of producing fusion proteins Grant 5,338,669 - Gillies * August 16, 1 | 1994-08-16 |
Method of producing engineered binding proteins Grant 5,196,320 - Gillies March 23, 1 | 1993-03-23 |
Enhanced production of proteinaceous materials in eucaryotic cells Grant 4,663,281 - Gillies , et al. May 5, 1 | 1987-05-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.